Krsnaa Diagnostics Limited

NSE KRSNAA.NS

Krsnaa Diagnostics Limited Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -15.45 M

Krsnaa Diagnostics Limited Net Cash Used For Investing Activities is USD -15.45 M for the year ending March 31, 2024, a -16.62% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Krsnaa Diagnostics Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -13.25 M, a 58.20% change year over year.
Krsnaa Diagnostics Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -31.69 M, a -279.55% change year over year.
Krsnaa Diagnostics Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -8.35 M, a 17.91% change year over year.
Krsnaa Diagnostics Limited Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -10.17 M, a 64.53% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

NSE: KRSNAA.NS

Krsnaa Diagnostics Limited

CEO	Mr. Mitesh Dave
IPO Date	Aug. 16, 2021
Location	India
Headquarters	S.No.243,A-Hissa No.6/6
Employees	3,700
Sector	Health Care
Industries Telehealth Hospitals & Clinics Medical Instruments Professional Services

Description

Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.

Key trends

Past 5 years